Indian demand for COVID-19 drug remdesivir rising sharply: Cipla ...Middle East

Demand for COVID-19 antiviral drug remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts remain divided over its effectiveness. Remdesivir was developed by U.S. drugmaker Gilead Sciences Inc, which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of the treatment. Cipla is among several firms licensed to make and sell generic versions in developing nations.

Hence then, the article about indian demand for covid 19 drug remdesivir rising sharply cipla was published today ( Monday 09/11/2020 - 12:45 PM ) and is available on Yahoo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Indian demand for COVID-19 drug remdesivir rising sharply: Cipla )

Also on site :

• 2 die in apparent murder-suicide at La Habra Korean BBQ restaurant
• Russia to test all labor migrants for hepatitis
• Skelton: Katie Porter’s meltdown opens the door for this L.A. Democrat